Equities

Eiken Chemical Co Ltd

Eiken Chemical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,172.00
  • Today's Change3.00 / 0.14%
  • Shares traded98.40k
  • 1 Year change+39.68%
  • Beta0.3587
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments16,30818,31716,121
Total Receivables, Net12,47511,11611,964
Total Inventory8,0978,4128,230
Prepaid expenses------
Other current assets, total9711,372724
Total current assets37,85139,21737,039
Property, plant & equipment, net17,00517,20215,275
Goodwill, net------
Intangibles, net7921,0541,350
Long term investments5975863,614
Note receivable - long term------
Other long term assets3,1502,7652,751
Total assets61,65166,27562,512
LIABILITIES
Accounts payable7,4077,6187,456
Accrued expenses674766776
Notes payable/short-term debt000
Current portion long-term debt/capital leases384390393
Other current liabilities, total2,8863,6693,908
Total current liabilities11,35112,44312,533
Total long term debt3,9513,9193,798
Total debt4,3354,3094,191
Deferred income tax------
Minority interest------
Other liabilities, total378378378
Total liabilities15,68016,74016,709
SHAREHOLDERS EQUITY
Common stock6,8976,8976,897
Additional paid-in capital7,8928,0768,000
Retained earnings (accumulated deficit)36,15937,24533,478
Treasury stock - common(5686)(3095)(3126)
Unrealized gain (loss)352833
Other equity, total674384521
Total equity45,97149,53545,803
Total liabilities & shareholders' equity61,65166,27562,512
Total common shares outstanding353737
Treasury shares - common primary issue5.446.516.58
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.